Close Menu

In this week's Science, a University of California, Los Angeles-led team publishes a study showing that small cell neuroendocrine carcinomas (SCNCs) — highly lethal tumors that can arise from the "reprogramming" of different types of epithelial cancer, often in patients resistant to targeted therapies — have common molecular drivers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.